Clinical Trials Browser

Phase 3 × OTHER × Patient Preference × Clear all

NCT04409288 2024-01-05

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms, Patient Preference

NCT01906073 2020-12-10

NFCP-2

Phase 3 Withdrawn

Neoplasms, Pain, Patient Satisfaction, Patient Preference